Does CBD Play a Role in Acne Treatment?
Drug Topics
NOVEMBER 11, 2022
CBD therapy has had positive outcomes in other inflammatory conditions.
November, 2022
568 
5 enduring mysteries of the Barry and Honey Sherman murders
PharmaVoice
NOVEMBER 28, 2022
After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Expanding the WTO intellectual property waiver will hurt American jobs
PhRMA
NOVEMBER 9, 2022
The June decision by WTO members to waive commitments to protect intellectual property (IP) for COVID-19 vaccines under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was a political and ineffective measure that does not address the true barriers to vaccine equity. Now, some are pushing to extend this harmful waiver to COVID-19 treatments, even though production exceeds demand for treatments, including for the most effective antivirals and monoclonal antibodies.
The Bug Name Emoji Game
IDStewardship
NOVEMBER 13, 2022
On this webpage you will find “The Bug Name Emoji Game” which is just like “ The Drug Name Emoji Game ” and meant to be a fun medical emoji puzzle game for people who deal with different types of microbial pathogens. Simply use the emoji symbols to decipher the corresponding organism name! These puzzles have been developed by Dr.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Higher Incidence of Myocarditis, Pericarditis Found After COVID-19 Vaccination
Pharmacy Times
NOVEMBER 14, 2022
Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.
More vaccinated than unvaccinated died from COVID-19 in August: analysis
Fierce Healthcare
NOVEMBER 28, 2022
More vaccinated than unvaccinated died from COVID-19 in August: analysis. fdiamond. Mon, 11/28/2022 - 16:34.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
The next era of Greater Boston’s biotech boom
PharmaVoice
NOVEMBER 22, 2022
How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth.
What you should know about RSV
PhRMA
NOVEMBER 15, 2022
You are probably reading a lot about a surge of cases of respiratory viruses like respiratory syncytial virus (RSV), influenza (the flu) and SARS-CoV-2, which causes COVID-19. The triple threat of these highly contagious respiratory viruses circulating simultaneously is causing a ripple of effects on patients, health care providers and our health care system as a whole.
Opinion: A tripledemic hurricane is making landfall. We need masks, not just tent hospitals
STAT
NOVEMBER 22, 2022
A viral hurricane is making landfall on health care systems battered by three pandemic years. With the official start of winter still weeks away, pediatric hospitals are facing crushing caseloads of children sick with RSV and other viral illnesses. Schools that promised a “return to normal” now report widespread absences and even closures from RSV and flu in many parts of the country , contributing to parents missing work in record numbers.
Expert: Deprescribing Is an Important Part of End-of-Life Care
Pharmacy Times
NOVEMBER 7, 2022
A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
AI will continue to attract investment in near future in the healthcare industry
Pharmaceutical Technology
NOVEMBER 25, 2022
Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’. In this survey-based report tracker, digital media was prioritised as a top current investment target, with 53% of surveyed respondents confirming that their companies are currentl
Working With Discount Cards and Manufacturer Coupons
Drug Topics
NOVEMBER 16, 2022
Discount cards and manufacturer coupons can cost pharmacies in the long run.
The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur
PharmaVoice
NOVEMBER 11, 2022
Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
‘A very worrying scenario’: Internal documents on India Covid-19 vaccine raise troubling questions about approval process
STAT
NOVEMBER 15, 2022
As the Covid-19 pandemic spread across the world two years ago, one of India’s leading biotech companies was racing to develop a vaccine with crucial backing from the Indian government. The shot engineered by Bharat Biotech was, in part, an important effort to create a home-grown product that could bolster the fortunes of the Indian pharmaceutical industry.
Proof-of-Concept Study Shows Positive Results for Novel HIV Treatment
Pharmacy Times
NOVEMBER 3, 2022
Investigational broadly neutralizing antibody shows promise as potential as a first-in-class treatment option for HIV.
AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments
Fierce Pharma
NOVEMBER 10, 2022
AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. aliu. Thu, 11/10/2022 - 09:02.
Boost Medication Adherence With Personalized Solutions
Drug Topics
NOVEMBER 10, 2022
Medication only works when it's taken, which makes adherence necessary. The approach can't be "one size fits all".
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
4 pioneering social media campaigns in pharma this year
PharmaVoice
NOVEMBER 17, 2022
The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate.
New data show how insurers and middlemen shift Rx costs onto patients
PhRMA
NOVEMBER 16, 2022
There is only one place in the health care system where middlemen refuse to share negotiated prices with patients, and that’s at the pharmacy counter. A new report reveals how this harmful tactic leads to higher costs for patients.
Holmes gets more than 11 years in prison for Theranos scam
STAT
NOVEMBER 18, 2022
A federal judge on Friday sentenced disgraced Theranos CEO Elizabeth Holmes to more than 11 years in prison for duping investors in the failed startup that promised to revolutionize blood testing but instead made her a symbol of Silicon Valley’s culture of audacious self-promotion. The sentence imposed by U.S. District Judge Edward Davila was shorter than the 15-year penalty requested by federal prosecutors but far tougher than the leniency her legal team sought for the mother of a year-o
Dental Health Plays Vital Role in Cardiovascular Well-Being
Pharmacy Times
NOVEMBER 21, 2022
Research also focuses on connection between oral hygiene and other chronic diseases, neurological disorders, pulmonary infections.
From finding the right candidates to keeping them, how hospitals are using AI to address workforce needs
Fierce Healthcare
NOVEMBER 18, 2022
From finding the right candidates to keeping them, how hospitals are using AI to address workforce needs. aburky. Fri, 11/18/2022 - 15:25.
More Americans Lack a Consistent Source of Health Care
Drug Topics
NOVEMBER 17, 2022
Health disparities in care were made worse by the pandemic.
In cancers with very low survival rates, Sellas aims higher
PharmaVoice
NOVEMBER 21, 2022
The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer.
The 340B program is interfering with the U.S. biosimilars market and impacting patient costs
PhRMA
NOVEMBER 21, 2022
Research has shown that 340B hospitals are more likely to prescribe more expensive medicines and significantly mark up the price of medicines. For example, 340B hospitals received nearly five times what they paid, on average, to acquire oncology medicines through 340B. These practices have implications for what patients pay out of pocket — and new research adds to the evidence.
Early cell therapy successes start to turn the tide in lupus
Pharmaceutical Technology
NOVEMBER 14, 2022
In a field dominated by antibodies and small molecules, two cell-therapy based approaches have come under the spotlight for showing early signs of efficacy in treating lupus. In September, a group from Friedrich Alexander University Erlangen-Nuremberg reported that five patients with lupus achieved remission after an infusion of autologous chimeric antigen receptor (CAR)-T cells led to a deep depletion of B cells.
Educating Patients with Chronic Kidney Disease Can Reduce Mortality Risk
Pharmacy Times
NOVEMBER 6, 2022
Active patient care with chronic kidney disease may provide enormous benefits for patients, the economy, and society.
After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback
STAT
NOVEMBER 29, 2022
He Jiankui, the Chinese biophysicist who created the first gene-edited children , had been quiet since completing a three-year prison sentence in April, leaving many to wonder whether he had plans to return to scientific research. Earlier this month, we got his answer. On Nov. 9, He posted photos to Twitter of himself sitting at a computer in a white office.
Are Cannabinoids Key to Harm Reduction in Opioid Use Disorder?
Drug Topics
NOVEMBER 7, 2022
Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.
Why the biopharma ‘IPO playbook’ changed in 2022
PharmaVoice
NOVEMBER 21, 2022
Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.
Traditional HTA methods treat everyone like the “average” patient
PhRMA
NOVEMBER 7, 2022
Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments. It’s important to consider the best available information and evidence when making health care decisions.
Amazon's latest push into digital health—a virtual clinic for common conditions like allergies and hair loss
Fierce Healthcare
NOVEMBER 15, 2022
Amazon's latest push into digital health—a virtual clinic for common conditions like allergies and hair loss. hlandi. Tue, 11/15/2022 - 09:18.
Let's personalize your content